Jung M, Nicholas N, Grindrod S, Dritschilo A, et al. Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth. PLoS One 2024;19:e0306168.
PMID: 39008483